Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind Randomized Placebo-controlled Study to Evaluate the Efficacy and Safety of Intermittent, Long-term Administration of Levosimendan in Patients With Advanced Heart Failure

NCT00988806 is registered in ClinicalTrials.gov with Hospital Universitario de Canarias as lead sponsor.

NCT NCT00988806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00988806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind Randomized Placebo-controlled Study to Evaluate the Efficacy and Safety of Intermittent, Long-term Administration of Levosimendan in Patients With Advanced Heart Failure
Lead sponsor
Hospital Universitario de Canarias
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2009
Completion date
December 31, 2014
Enrollment
213 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced heart failure